{"data":{"type":"feed_item","id":336355,"entity_id":"wefunder:feed_item:336355","attributes":{"canonical_url":"https://wefunder.com/feed/336355","retrieval_urls":{"canonical":"https://wefunder.com/feed/336355","json":"https://wefunder.com/feed/336355.json","markdown":"https://wefunder.com/feed/336355.md","ai_json":"https://wefunder.com/feed/336355.ai.json","ai_text":"https://wefunder.com/feed/336355.ai.txt","changelog_json":"https://wefunder.com/feed/336355.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-18T02:15:32.622Z","generated_at":"2026-06-18T21:47:35Z","profile_visibility":"public","feed_item":{"id":336355,"entity_id":"wefunder:feed_item:336355","type":"FeedItem::Update","title":"New clinical data, new deck — and an FDA meeting on July 1 | Sen-Jam Pharmaceutical","content_plain":"Dear Wefunder Investors \u0026amp; Community, Three quick updates from Sen-Jam: 1. Clinical results — video link. Two trials converged on one patented biomarker signature (NLR) — our proof that this is a platform, not a single drug. 2. New investor dec...","published_at":"2026-06-13T17:58:12.630Z","updated_at":"2026-06-18T02:15:32.622Z","canonical_url":"https://wefunder.com/feed/336355","author":{"name":"Jim Iversen","profile_url":"https://wefunder.com/jimiversen2"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-06-18T02:15:32Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-06-18T02:15:32Z","as_of":"2026-06-18T02:15:32Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-06-18T02:15:32Z","as_of":"2026-06-13T17:58:12Z","confidence":"high"}}}}}}